MENA MedTech Insights

This episode of MENA MedTech Insights dives into a critical regulatory challenge in Saudi Arabia: how the Saudi Food and Drug Authority (SFDA) differentiates between a low-risk medical device and a general wellness or non-medical product. We explore how a product's intended use and marketing claims are the ultimate deciding factors, directly impacting your path to market access. Understanding this...

This episode of MENA MedTech Insights tackles a crucial question for manufacturers: Do Class I medical devices have reduced registration fees in Jordan? We dive deep into the Jordan Food and Drug Administration (JFDA) regulations to reveal that the official application fee is only the beginning of the story. We uncover the hidden costs, the critical importance of a well-prepared technical dossier,...

In this episode of MENA MedTech Insights, we demystify the process of registering low-risk medical devices in the GCC. We uncover the single most effective strategy to accelerate your market entry into key territories like Saudi Arabia and the UAE, saving you crucial time and resources. We explore how leveraging existing approvals from globally recognized bodies can transform a lengthy, complex pr...

This episode of MENA MedTech Insights tackles a crucial question for manufacturers entering the UAE market: Is a full technical file needed to register a Class A medical device in Dubai? While the initial submission process seems straightforward, a common misunderstanding can lead to severe compliance issues and market access withdrawal. We explore the critical difference between what you must sub...

In this episode of MENA MedTech Insights, we uncover the truth about registering low-risk medical devices in Qatar. Contrary to common belief, Qatar's Ministry of Public Health (MOPH) does not offer a simple notification process. Instead, all devices, regardless of class, must undergo a formal registration that heavily relies on prior approval from a recognized reference country like the US or EU....

Many MedTech manufacturers, particularly those with Class I devices, often underestimate the regulatory hurdles in the MENA region. This episode tackles a frequently asked and critically important question: Is a local Authorized Representative really necessary for a low-risk Class I medical device in Saudi Arabia? The answer might surprise you and could be the difference between successful market...

In this episode of MENA MedTech Insights, we tackle a critical and often misunderstood question: are low-risk medical devices exempt from registration in Egypt? Many manufacturers, accustomed to other markets, assume their Class I or Class A devices have a free pass, leading to costly delays and compliance issues. We break down the reality of the Egyptian Drug Authority's (EDA) regulations. We exp...

In this episode of MENA MedTech Insights, we provide a detailed, step-by-step guide for registering a low-risk, Class A medical device in the United Arab Emirates. We break down the specific requirements set by the UAE's Ministry of Health and Prevention (MOHAP), from the critical first step of appointing a local Authorized Representative to the final submission and review process. Discover the co...

In this episode of MENA MedTech Insights, we uncover the essential steps for registering a Class I medical device in Saudi Arabia. Many companies underestimate this process, believing it to be a simple notification. We reveal why it's a comprehensive Medical Device Marketing Authorization (MDMA) that requires careful planning, local representation, and precise documentation to succeed in the Kingd...

The Medical Device Single Audit Program (MDSAP) simplifies access to major global markets, but its acceptance in the MENA region, particularly Kuwait, remains a gray area. This episode of MENA MedTech Insights cuts through the ambiguity, offering a clear, experience-based perspective on how your MDSAP certification can impact your medical device registration in Kuwait. We move beyond official regu...

In this episode of MENA MedTech Insights, we provide a crucial guide to the post-market surveillance (PMS) requirements for medical devices in Qatar. As one of the fastest-growing healthcare markets in the Gulf Cooperation Council (GCC), Qatar's regulatory environment, overseen by the Ministry of Public Health (MOPH), demands rigorous post-market vigilance from manufacturers to ensure patient safe...

In this episode of MENA MedTech Insights, we debunk the common myth that a CE mark is an all-access pass to the Middle East and North Africa's booming medical device market. While essential, it's only the first step. We explore the nuanced "CE-plus" regulatory models in key jurisdictions that often surprise even experienced manufacturers. We break down the specific requirements for market entry in...

This episode of MENA MedTech Insights provides a detailed guide to registering a Class II medical device in Jordan. We explore the critical role of the Jordan Food and Drug Administration (JFDA) and break down the essential steps for foreign manufacturers, from appointing a local representative to compiling a compliant technical dossier. We delve into the specific documentation required, including...

This episode of MENA MedTech Insights dives deep into the true cost of medical device registration in the GCC, moving beyond the well-known government fees. We uncover the various hidden expenses that can surprise manufacturers, including mandatory local representation, document translation, and embassy legalization costs, providing a realistic financial picture for entering key markets like Saudi...

This episode of MENA MedTech Insights dives deep into a crucial, and often underestimated, aspect of entering the Egyptian medical device market: the strict Arabic labeling requirements set by the Egyptian Drug Authority (EDA). We explore the dual-language mandate and uncover the common pitfalls that can lead to significant delays and financial losses for manufacturers. Imagine your company has sp...

In this episode of MENA MedTech Insights, we tackle a critical strategic decision for any medical device manufacturer looking to enter the Kingdom of Saudi Arabia: choosing your Authorized Representative (AR). This SFDA requirement is more than a formality; it's a choice that can define your operational freedom and long-term success in the market. We explore the two main pathways: appointing your...

This episode of MENA MedTech Insights dives deep into the complex world of medical device classification across the Middle East and North Africa. We move beyond the basics of risk-based classes to uncover the single most important factor for market access: reference country approvals. Learn how regulators in key markets like Saudi Arabia and the United Arab Emirates leverage prior approvals from t...

The UAE boasts one of the most advanced healthcare systems in the MENA region, but accessing this lucrative market requires a deep understanding of the Ministry of Health and Prevention (MOHAP) regulations. This episode provides a practical, step-by-step guide for MedTech manufacturers aiming for successful market entry, transforming complex regulatory hurdles into a clear path to approval. We bre...

This episode of MENA MedTech Insights dives deep into the specific requirements for medical device registration with the Saudi Food and Drug Authority (SFDA). We uncover the critical steps and common pitfalls foreign manufacturers face when trying to enter one of the largest and fastest-growing healthcare markets in the Middle East. We explore why your choice of a local Authorized Representative c...

In this episode of MENA MedTech Insights, we demystify the process of medical device registration in Saudi Arabia. We explore why the Saudi Food and Drug Authority (SFDA) is a critical gatekeeper to one of the fastest-growing healthcare markets and break down the common hurdles that international manufacturers face. We move beyond the basics of GHTF prerequisites and dive into the specific nuances...